myoblast; skeletal muscle; differentiation; extracellular signal-regulated kinase; myogenin SKELETAL MYOGENESIS is characterized by a multistep process in which mononucleated, undifferentiated myoblasts proliferate (proliferation), withdraw from the cell cycle, and then differentiate into mononucleated myocytes (early differentiation), which subsequently fuse into multinucleated myotubes expressing muscle-specific proteins (late differentiation) to form the mature muscle fiber (terminal differentiation) (16) . Myogenic regulatory factors (MRFs), which belong to the basic helix loop-helix family of transcription factors, in cooperation with E2A and myocyte enhancer factor (MEF)2 families, activate the differentiation program by inducing the transcription of regulatory and structural muscle-specific genes (2-4, 16, 18, 29) . In addition to these regulators, skeletal myogenesis is regulated by signal transduction cascades with the complex involvement of several kinases, including ERK (1, 10, 16, 26, 30, 38, 42) . In proliferating myoblasts, the ERK pathway contributes to repress myogenic transcription and maintain the undifferentiated phenotype. At the onset of differentiation, the decline of ERK activity relieves the repressed myogenic transcription. Once the activation of the myogenic program is initiated, ERK activation is required to promote myogenic differentiation. Thus, ERK shows a biphasic activation profile with peaks in undifferentiated myoblasts and postmitotic myotubes and is suggested to have a dual role during myogenic differentiation, being inhibitory at the early stage and stimulatory at the late stage (38) . However, the molecular mechanisms of skeletal myogenesis have not been fully elucidated.
We have recently identified a novel muscle-restricted coiledcoil protein, MURC, which is evolutionarily conserved from the frog to human (22) . MURC is expressed in cardiomyocyes, smooth muscle cells, and skeletal myocytes. In the murine adult heart, MURC was localized to the cytoplasm with accumulation in the Z-line of the sarcomere. MURC mRNA expression in the heart increased during the developmental process from the embryonic stage to adulthood. In response to pressure overload, MURC mRNA expression increased in the hypertrophied heart. Forced overexpression of MURC in cardiomyocytes induced the activation of the RhoA/Rho-associated kinase (ROCK) pathway, which modulated serum response factor (SRF)-mediated atrial natriuretic peptide (ANP) expression and myofibrillar organization. Sustained overexpression of MURC in the heart induces cardiac dysfunction and conduction disturbances with an increased vulnerability to atrial arrhythmias in mice.
In this study, we examined the role of MURC in skeletal myogenesis. MURC expression was induced during myogenic differentiation in vitro and in vivo. In C2C12 myoblasts, RNA interference (RNAi)-mediated knockdown of MURC impaired myogenic differentiation, which was accompanied by impaired myogenin expression and ERK activation at the later stages of differentiation. Overexpression of MURC in C2C12 myoblasts promoted differentiation into myotubes with enhanced myogenin expression and ERK activation during differentiation.
MATERIALS AND METHODS
Immunofluorescence microscopy. Specimens were fixed in 4% paraformaldehyde and stained with rabbit polyclonal anti-MURC antibody (22) , mouse monoclonal anti-␣-actinin antibody, mouse monoclonal anti-embryonic myosin antibody (F1.652, Developmental Studies Hybridoma Bank), or mouse monoclonal anti-sarcomeric myosin antibody (MF20, Developmental Studies Hybridoma Bank). Secondary antibodies were conjugated with Alexa fluor 488, 555, or 594 (Invitrogen), and nuclei were visualized using 4Ј,6-diamino-2-phenylindole (Invitrogen). The number of nuclei per myotube and the fusion index were analyzed as previously described (21) . Briefly, the average number of nuclei per myotube was determined from randomly chosen myosin-positive cells containing 2 or more nuclei, and 3,000 nuclei per culture were counted. The fusion index was calculated from the ratio of the number of nuclei in myotubes with 2 or more nuclei to the total number of nuclei, and 1,000 myotube nuclei were counted.
Cell culture and induction of differentiation. C2C12 cell culture and differentiation were performed as previously described (21) . Briefly, myogenesis was induced by changing the medium to DMEM supplemented with 2% horse serum after the cells were grown to confluence in growth medium.
RNA extraction and quantitative RT-PCR. Total RNA was extracted from cells using an RNeasy mini kit (QIAGEN). cDNA synthesis and quantitative real-time PCR were performed as previously described (22, 23, 33) . Mouse GAPDH or ␤-tubulin was used for normalization, and the comparative threshold method was used to assess the relative abundance of the targets. The primers used were as follows: MURC, forward primer 5Ј-ACA GTC ACA CAG CAA TAC GGG CTA-3Ј and reverse primer 5Ј-TTC TCG GGC AGG CTT CTG TCT TTA-3Ј; myogenin, forward primer 5Ј-TAC GTC CAT CGT  GGA CAG CAT-3Ј and reverse primer 5Ј-TCA GCT AAA TTC CCT  CGC TGG-3Ј; MyoD, forward primer 5Ј-TGA GCA AAG TGA ATG  AGG CCT TCG-3Ј and reverse primer 5Ј-TGC AGA CCT TCG ATG  TAG CGG AT-3Ј; muscle creatine kinase (MCK), forward primer  5Ј-CAC CTC CAC AGC ACA GAC AG-3Ј and reverse primer  5Ј-ACC TTG GCC ATG TGA TTG TT-3Ј; and GAPDH, forward  primer 5Ј-TTG TGA TGG GTG TGA ACC ACG AGA-3Ј and  reverse primer 5Ј-CAT GAG CCC TTC CAC AAT GCC AAA-3Ј .
Western blot analysis. Cell lysates were extracted with lysis buffer containing 50 mM Tris⅐HCl (pH 7.4), 150 mM NaCl, 1 mM EDTA, 1% Nonidet P-40, 1 mM PMSF, 1ϫ protease inhibitor cocktail (Pierce), 1 mM Na 3VO4, and 1 mM NaF. Cell lysates were electrophoresed in 10% SDS-polyacrylamide gels and transferred to polyvinylidene difluoride membranes (Millipore). Membranes were incubated with primary antibodies against MURC, F1.652, MF20, Flag (Sigma), phospho-ERK (Thr 202 /Tyr 204 ), ERK (Cell Signaling), or GAPDH (Chemicom). Horseradish peroxidase-conjugated anti-rabbit IgG and anti-mouse IgG (GE Healthcare) were used as secondary antibodies.
Plasmid construction. The corresponding cDNA fragments for mouse MURC (mMURC) were cloned by PCR with a mouse heart cDNA template as previously described (22) . PCR was performed using the following primers: mMURC, forward primer 5Ј-ATG GAA CAC AAC GGA TCA GCT-3Ј and reverse primer 5Ј-CTA TTT GTA GTC TGA GGA CTG CTT TAG CTC CA-3Ј. cDNA encoding mMURC with a COOH-terminal Flag epitope and LacZ were cloned into the pMSCVpuro Retroviral Vector (Clontech) to generate pMSCVpuro-MURC and pMSCVpuro-LacZ, respectively. RNAi target sequences for mMURC (5Ј-GCT ACG TTG TCA ACA AGC TG-3Ј and 5Ј-AGA AAG TGA GTG GGA TTA GAA-3Ј) were cloned into the BamHI-EcoRI site of the RNAi-Ready-pSIRENRetroQ vector (Clontech) as an inverted repeat with a hairpin loop spacer to generate RNAi-Ready-pSIREN-RetroQ-mMURC1 and RNAi-Ready-pSIREN-RetroQ-mMURC2, respectively.
Recombinant retroviruses and gene transfer. To generate recombinant retroviruses, GP2-293 cells (Clontech) were cotransfected with the helper vector pVSV-G, pMSCVpuro-MURC, pMSCVpuroLacZ, RNAi-Ready-pSIREN-RetroQ-luciferase (Clontech), RNAiReady-pSIREN-RetroQ-mMURC1, and RNAi-Ready-pSIRENRetroQ-mMURC2 using FuGENE6 (Roche). pMSCVpuro-LacZ and RNAi-Ready-pSIREN-RetroQ-luciferase were used as controls. The medium supernatant was collected and centrifuged to concentrate virus stocks according to the manufacturer's instructions. Cells were infected with the retrovirus in the presence of 4 g/ml polybrene for 24 h, and the medium was changed to fresh medium. Infected cells were selected with 2.5 g/ml puromycin and analyzed.
Replication-defective recombinant adenoviruses and gene transfer. Recombinant adenoviruses expressing Flag-tagged mMURC (Ad-MURC) and LacZ (Ad-LacZ) were generated as previously described (22, 34) . C2C12 cells were infected with Ad-MURC or Ad-LacZ diluted in growth medium at a multiplicity of infection of 10 and incubated at 37°C for 1 h. The viral suspension was removed, and cells were cultured with growth medium.
Induced regeneration of skeletal muscle. Induction of muscle regeneration was performed as previously described with minor modifications (25, 36) . Male mice were anesthetized with 2,2,2-tribromoethanol (0.25 mg/g, Aldrich). An incision was performed to expose the tibialis anterior muscle. Muscle damage was induced by the direct application of a 5-mm metal probe precooled in liquid nitrogen to the surface of the exposed muscle for 15 s. At different times after injury, mice were euthanized, and muscles were removed. All of the aspects of animal care and experimentation performed in this study were approved by the Institutional Animal Care and Use Committee of Kyoto University.
Statistical analysis. All experiments were performed at least three times. Data are expressed as means Ϯ SE and were analyzed by one-way ANOVA with post hoc analysis. A value of P Ͻ 0.05 was considered significant.
RESULTS

Subcellular localization of MURC in skeletal muscle.
We have shown previously that MURC was localized to the cytoplasm with an accumulation in the Z-line of the sarcomere in the murine adult heart (22) . To determine the subcellular localization of MURC in skeletal muscle, adult mouse gastrocnemius muscle sections were immunostained with an anti-MURC antibody. Consistent with our previous data in the heart, MURC staining was detected in the cytoplasm with a striated and periodic staining pattern and partly colocalized with ␣-actinin in the Z-line (Fig. 1) .
MURC expression in C2C12 myoblasts during myogenesis. We used C2C12 myoblasts that could be induced to differentiate into myotubes by serum starvation and assessed MURC expression during differentiation into myotubes. In C2C12 myoblasts, MURC mRNA expression was induced as early as day 1 after the induction of differentiation and then reached a maximum on day 2, and its level continued up to day 6 ( Fig. 2A) . The expression pattern of myogenin mRNA was similar to that of MURC mRNA because the induction of myogenin mRNA expression was detectable on day 1 and its expression peaked on day 2, but the expression level declined on day 4. On the other hand, MyoD mRNA expression was already detectable in undifferentiated myoblasts, and its level was almost constant during myogenesis. MURC protein expression was then examined by Western blot analysis. MURC protein expression was not detected in undifferentiated myoblasts, but its expression was activated after 1 day of serum starvation and increased gradually up to day 6 (Fig. 2B) . Sarcomeric myosin protein expression followed MURC and embryonic myosin protein expression. As shown in Fig. 2C , immunostaining analysis showed that myotubes stained with an anti-sarcomeric myosin antibody expressed MURC. Thus, the induction of MURC expression occurred in differentiating muscle cells and preceded that of sarcomeric myosin expression.
RNAi-mediated knockdown of MURC in C2C12 myoblasts
inhibits myogenesis. The above observations prompted us to investigate whether MURC might be involved in skeletal myogenesis. To investigate the biological role of endogenous MURC expression during myogenesis, RNAi using mMURC short-hairpin RNA (shRNA) was performed in C2C12 myoblasts. We made recombinant retroviruses expressing Flag-tagged mMURC, mMURC-shRNA1, and mMURC-shRNA2. C2C12 myoblasts were infected with recombinant retrovirus expressing Flag-tagged mMURC and/or recombinant retroviruses expressing mMURCshRNA1 or mMURC-shRNA2, which confirmed that the protein expression of Flag-tagged mMURC was reduced by mMURCshRNA1 and mMURC-shRNA2 (data not shown). We then infected C2C12 cells with recombinant retroviruses expressing luciferase-shRNA, mMURC-shRNA1, and mMURC-shRNA2 and generated C2C12 cells expressing luciferase-shRNA (C2C12-Luc-shRNA), mMURC-shRNA1 (C2C12-mMURC-shRNA1), and mMURC-shRNA2 (C2C12-mMURC-shRNA2). Upon the induction of differentiation, endogenous MURC mRNA and protein expression were attenuated in both C2C12-mMURCshRNA1 and C2C12-mMURC-shRNA2 cells compared with C2C12-Luc-shRNA cells (Fig. 3A) . Since MURC RNAi was achieved more efficiently in C2C12-mMURC-shRNA1 cells than C2C12-mMURC-shRNA2 cells, we used C2C12-mMURCshRNA1 cells and examined the expression levels of myogenin, MyoD, MCK, and sarcomeric myosin during myogenesis. As shown in Fig. 3B , myogenin mRNA expression was attenuated on days 2 and 3 in C2C12-mMURC-shRNA1 cells compared with C2C12-Luc-shRNA cells. MCK mRNA expression was reduced on days 4 and 6 in C2C12-mMURC- shRNA1 cells. Consistent with these observations, sarcomeric myosin expression during myogenesis was impaired in C2C12-mMURC-shRNA1 cells compared with C2C12-Luc-shRNA cells (Fig. 3C) . Immunostaining analysis showed that myotube formation was also impaired in C2C12-mMURC-shRNA1 cells compared with C2C12-Luc-shRNA cells, and this observation was confirmed in C2C12-mMURC-shRNA2 cells (Fig.  3D) . Furthermore, to exclude off-target effects of the mMURC-shRNA used, C2C12-mMURC-shRNA1 cells were infected with Ad-MURC. As shown in Fig. 3E , compared with C2C12-mMURC-shRNA1 cells infected with Ad-MURC and C2C12-mMURC-shRNA1 cells infected with Ad-LacZ at day 6 after the induction of differentiation, the forced expression of Flag-tagged MURC using Ad-MURC resulted in increases in MURC protein expression and sarcomeric myosin protein expression. In accordance with this finding, myotube formation in C2C12-mMURC-shRNA1 cells infected with Ad-MURC was promoted compared with that in C2C12-mMURCshRNA1 cells infected with Ad-LacZ (Fig. 3F) . These results indicate that MURC has at least an important permissive role in myogenesis in C2C12 cells.
MURC RNAi impaired ERK activation during myogenesis in C2C12 myoblasts. ERK has been reported to have a key role in the differentiation into myotubes (1, 10, 30, 38) . To reveal the role of MURC in the signaling pathway involved in myogenic differentiation, we investigated ERK activation in C2C12 myoblasts. Consistent with a previous report (38) , ERK phosphorylation decreased at the onset of differentiation, reached a minimum at day 2 after differentiation, and increased at later stages of differentiation in C2C12-Luc-shRNA cells (Fig. 4A) . We obtained a similar pattern of ERK phosphorylation in naïve C2C12 cells (data not shown). In C2C12-mMURC-shRNA1 cells, ERK phosphorylation was impaired at the later stages of differentiation (Fig. 4, A and B) . To examine whether ERK activation at the later stages is required for differentiation in C2C12 cells, we used PD-98059, a MEK inhibitor. Upon the induction of differentiation in C2C12 cells treated with PD-98059 at 25 M for 3 days, inhibition of ERK phosphorylation Immunostaining was performed using C2C12-Luc-shRNA, C2C12-mMURC-shRNA1, and C2C12-mMURC-shRNA2 cells at 6 days after the induction of differentiation with an anti-sarcomeric myosin antibody. Nuclei were stained by DAPI (blue). Bottom, higher magnification images. E: expression of MURC protein and sarcomeric myosin protein in C2C12-mMURC-shRNA1 cells. C2C12-mMURC-shRNA1 cells were infected with Ad-LacZ or Ad-MURC. Cell lysates from C2C12-mMURC-shRNA1 cells infected with Ad-LacZ and Ad-MURC at 6 days after the induction of differentiation were immunoblotted with antibodies recognizing Flag, MURC, sarcomeric myosin, and GAPDH. F: immunostaining of differentiated C2C12-mMURC-shRNA1 cells. Immunostaining was performed using C2C12-mMURC-shRNA1 cells infected with Ad-LacZ and Ad-MURC at 6 days after the induction of differentiation with an anti-sarcomeric myosin antibody. Nuclei were stained by DAPI (blue). Bottom, higher magnification images.
in C2C12 cells at day 3 was observed ( Fig. 4C) . Myogenic differentiation was impaired in C2C12 cells treated with PD-98059 during both days 0 -6 and days 2-6, whereas it was not impaired in C2C12 cells treated with PD-98059 during days 0 -2 (Fig. 4D) . These results indicate that ERK activation at the later stages (days 2-6) is necessary for myogenic differentiation in C2C12 cells.
Overexpression of MURC in C2C12 myoblasts promotes myogenesis with enhanced ERK activation at later stages. We then examined whether MURC could promote myogenesis in C2C12 myoblasts. We used recombinant retroviruses expressing LacZ and Flag-tagged MURC and made C2C12 cells expressing LacZ (C2C12-LacZ) and MURC (C2C12-MURC), respectively (Fig. 5A) . Although the myogenin mRNA expression level was not altered in undifferentiated C2C12-MURC cells compared with C2C12-LacZ cells, after the induction of differentiation, its expression level was upregulated on days 2 and 3 during differentiation in C2C12-MURC cells compared with C2C12-LacZ cells (Fig. 5B) . The MyoD mRNA expression level in C2C12-MURC cells was not altered compared with C2C12-LacZ cells. The expression of MCK mRNA and sarcomeric myosin protein during myogenesis was accelerated and augmented in C2C12-MURC cells compared with C2C12-LacZ cells (Fig. 5, B and C) . Morphologically, differentiated myotubes on day 6 in C2C12-MURC cells were both longer and wider than those in C2C12-LacZ cells (Fig. 5D) . Consistent with this observation, the number of nuclei per myotube and the percentage of all nuclei present in myotubes (fusion index) on day 6 were significantly higher in C2C12-MURC cells than C2C12-LacZ cells (Fig. 5E ). These findings suggest that MURC can promote differentiation into multinucleated myotubes in C2C12 cells.
Although ERK phosphorylation was not affected in C2C12-MURC cells on day 0 compared with that in C2C12-LacZ cells on day 0, it was enhanced at the later stages of differentiation (Fig. 6, A and B) . Furthermore, myogenesis in C2C12-MURC cells was inhibited by treatment with PD-98059 during days 0 -6 (Fig. 6C) .
Upregulation of MURC expression and activation of ERK during injury-induced muscle regeneration in vivo.
Although the cell culture system used above is a valuable tool for the identification and characterization of myogenic pathways, it may only partially recapitulate the regulation of myogenesis. Therefore, we examined MURC expression and ERK activation in regenerating muscle tissue. We induced muscle damage by cryoinjury in the tibialis anterior muscle of adult mice. Muscle tissues before injury and at 1, 3, 5, and 9 days postinjury were collected and assessed by hematoxylin and eosin staining, Western blot analysis, and immunostaining. As shown in Fig. 7A , the muscle was destroyed at 1 day postinjury, and regeneration by satellite cells resulted in the formation of small, slightly basophilic, and centronucleated myofibers at 5 and 9 days postinjury. Western blot analysis showed that the MURC protein expression level decreased at 1 day postinjury, accompanied by muscle destruction, gradually increased during muscle regeneration, and was then restored at 9 days postinjury, whereas embryonic myosin was transiently expressed at 5 days postinjury (Fig. 7B) . Immunohistofluorescence analysis of regenerating muscle at 5 days postinjury showed that the abundance of MURC appeared higher in centronucleated and immature myofibers than in mature myofibers in which the nuclei occupied a peripheral position. During injury-induced muscle regeneration, Western blot analysis showed that ERK phosphorylation decreased at 1 day postinjury, accompanied by muscle destruction, and then increased at day 3 and continued up to day 9 (Fig. 7B) . To examine which cells account for ERK activation, immunostaining was performed. As shown in Fig. 7D , sections of regenerating muscle at 5 days postinjury revealed that phospho-ERK appeared in small, centronucleated, MURC-expressing myofibers, suggesting that ERK activation occurred in MURCexpressing immature myofibers during myogenesis in vivo.
DISCUSSION
The Z-disc is known to be not only simply the structural border of the sarcomere but also to function in sensing and transmitting external and internal signals, because various signaling molecules have been identified as components of the Z-disc, and a large number of the Z-disc-associated proteins have been shown to shuttle between the Z-disc and other subcellular locations to transmit signals (7, 14, 27) . We have previously shown that in vascular smooth muscle cells MURC was diffusely localized to the cytoplasm and that in cardiomyocytes MURC was partly localized in the Z-line of the sarcomere and functioned as a molecule involved in Rho/ROCK signaling (22) . In the present study, we showed that in skeletal muscle MURC staining was detected in the cytoplasm with a striated and periodic staining pattern and partly colocalized with ␣-actinin in the Z-line of the sarcomere. These findings suggest that in striated muscle MURC is a Z-disc-associated protein and functions as a molecule that shuttles between the Z-disc and other subcellular locations to transmit signals.
MURC was expressed as early as myogenin during the differentiation of myoblasts into myotubes, and knockdown and overexpression of MURC altered myogenin but not MyoD expression during myogenesis in C2C12 cells. Skeletal myogenesis is tightly controlled by the MRF family, which consists of MyoD, Myf5, myogenin, and MRF4 (2-4, 16, 29) . MyoD and Myf5 are required for the commitment of proliferating somitic cells to the myogenic lineage (28), whereas myogenin is required for committed cells (myoblasts) to differentiate into myocytes and mature into myofibers but is dispensable for establishing the myogenic lineage (12, 20, 29, 35) . MRF4 has functions of both commitment and differentiation in myogenesis (2, 15, 31, 44) . These data suggest that myogenin expression altered by MURC might be involved in the differentiation of myoblasts into myotubes. The induction of myogenin ex- pression has been reported to require an E box and a MEF2-binding site for proper expression (6, 41) . Rho family proteins have been shown to be required for the transcription of the myogenin gene during myogenesis (9, 32) . RhoA activates SRF-mediated gene expression (13, 19, 37) , and SRF is involved in myogenin expression during myogenesis in myoblast cell lines (37) . Our previous study suggested that MURC signaling regulates SRF-mediated ANP gene expression through the Rho/ROCK pathway in cardiomyocytes (22) . Furthermore, we examined the effect of MURC signaling on the transcription of the skeletal ␣-actin (SkA) gene to perform a luciferase reporter assay using the SkA promoter (kindly provided by Michael D. Schneider, Imperial College, London, UK), which has SRF binding sites (17) . MURC transactivated the SkA promoter, and MURC-induced transactivation of the SkA promoter was attenuated by the ROCK inhibitor Y-27632 (T. Ueyama, unpublished observations). Thus, our findings suggest that the Rho/ROCK pathway contributes to the SRFmediated gene transcription in MURC signaling. We found that the overexpression of MURC increased RhoA activity in undifferentiated C2C12 cells (C2C12-MURC cells, 4.70 Ϯ 0.89-fold, P Ͻ 0.05 compared with C2C12-LacZ cells). However, myogenin expression was not induced in undifferentiated C2C12-MURC cells, as shown in Fig. 5B . These findings suggest that the activation of the Rho pathway alone is not sufficient for myogenin expression in undifferentiated C2C12 cells and that additional signaling pathways activated during myogenesis cooperate with the Rho pathway to regulate myogenin expression modulated by MURC.
p38 MAPK has been shown to activate MEF2 family members (11, 24, 38, 40, 43) and stimulate skeletal myogenesis (8, 16, 42) . Therefore, we examined p38 MAPK activation during myogenesis in C2C12 cells. However, p38 MAPK activation during differentiation was not detected in either naïve C2C12 or C2C12-MURC cells. The system that we used might be under the sensitivity to detect the activation of p38 MAPK. On the other hand, we observed a biphasic change in ERK activity during myogenesis in C2C12 cells, which is consistent with the previous report by Wu et al. (38) . Wu et al. have shown that reactivated ERK during myogenesis cooperates with p38 MAPK in promoting myogenic differentiation (38) . We demonstrated that overexpression and knockdown of MURC modulated ERK reactivation in differentiating C2C12 myoblasts and that modulated ERK activation by the altered expression of MURC was correlated with myogenic responses. In addition, MURC expression was upregulated in immature muscle cells during muscle regeneration in vivo, and ERK phosphorylation was detected in small, centronucleated cells. These results Fig. 7 . MURC expression and ERK activation during injury-induced muscle regeneration. A: muscle regeneration induced by cryoinjury. Hematoxylin and eosin staining was performed using sections of the tibialis anterior muscle of the adult mouse with or without cryoinjury. B: expression of MURC and activated ERK during injury-induced muscle regeneration. Lysates of skeletal muscle with or without cryoinjury were immunoblotted with antibodies recognizing embryonic myosin, MURC, sarcomeric myosin, p-ERK, ERK, and GAPDH as an internal control. C: MURC expression in regenerating muscle. Immunostaining was performed using sections of the tibialis anterior muscle muscle at 5 days after cryoinjury with anti-MURC, anti-embryonic myosin, and anti-p-ERK antibodies. D: ERK activation in regenerating muscle. Immunostaining was performed using sections of the tibialis anterior muscle muscle at 5 days after cryoinjury with anti-MURC and anti-p-ERK antibodies. Nuclei were stained by DAPI (blue). Bottom, higher magnification images.
suggest the involvement of MURC in ERK activation during skeletal myogenesis both in vitro and in vivo. The Rho/ROCK pathway has been reported to contribute to the activation of ERK in cardiomyocytes (39) . In myogenic cells, ROCK2 and its alternatively spliced isoform ROCK2m have been shown to positively control the activation of ERK1/2 during myogenesis (26) . Therefore, the reactivation of ERK during myogenesis in C2C12 cells may be partly attributable to the Rho/ROCK pathway modulated by MURC. Our finding that treatment of naïve C2C12 and C2C12-MURC cells with PD-98059 impairs myogenesis suggests the requirement of the ERK/MEK1 pathway for myogenesis in both naïve C2C12 and C2C12-MURC cells. However, we also found that myogenic differentiation in C2C12-mMURC-shRNA1 cells infected with recombinant adenovirus expressing constitutively activated MEK1 (Ad-MEK1 EE) (34) at day 2 after the induction of differentiation was not promoted compared with that in C2C12-mMURCshRNA1 cells infected with Ad-LacZ at day 2 after the induction of differentiation (M. Tagawa and T. Ueyama, unpublished observations). Since recombinant adenovirus-mediated protein expression is induced as early as 12 h after infection, reaches a maximum on day 2, and then declines (5), the activity and activation pattern of ERK in C2C12-mMURC-shRNA1 cells infected with Ad-MEK1 EE probably differs from that in naïve C2C12 cells during myogenesis. In addition, infection of C2C12-mMURC-shRNA1 cells with Ad-MEK1 EE on day 2 should induce ERK activation in cells not committed to the myocyte lineage as well, which may affect the commitment to the myocyte lineage through paracrine effects. These might be due to the failure of forced activation of endogenous ERK by ectopic expression of MEK1 EE to rescue myogenic differentiation in C2C12-mMURC-shRNA1 cells. Collectively, our findings suggest that the activation of the ERK/MEK1 pathway is necessary but not sufficient for MURC-mediated myogenesis in C2C12 cells or that fine regulation of ERK/MEK1 signaling during myogenesis is required for MURC-mediated differentiation in C2C12 cells. Further studies are needed to clarify how MURC is involved in ERK reactivation during skeletal myogenesis and how the reactivation of ERK modulated by MURC is involved in skeletal myogenesis.
In conclusion, the present study demonstrates that MURC is expressed as early as myogenin and is upregulated in immature differentiating muscle cells during myogenesis. MURC regulates skeletal myogenesis accompanied by the modulation of myogenin expression and ERK activation. Further investigation of the role of MURC will provide insights into the molecular mechanisms that regulate skeletal muscle development and muscle degenerating diseases.
